BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25311276)

  • 1. Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images.
    Lorenzi M; Pennec X; Frisoni GB; Ayache N;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S42-52. PubMed ID: 25311276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discerning mild cognitive impairment and Alzheimer Disease from normal aging: morphologic characterization based on univariate and multivariate models.
    Liao W; Long X; Jiang C; Diao Y; Liu X; Zheng H; Zhang L;
    Acad Radiol; 2014 May; 21(5):597-604. PubMed ID: 24433704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A spatio-temporal reference model of the aging brain.
    Huizinga W; Poot DHJ; Vernooij MW; Roshchupkin GV; Bron EE; Ikram MA; Rueckert D; Niessen WJ; Klein S;
    Neuroimage; 2018 Apr; 169():11-22. PubMed ID: 29203452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
    Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
    Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How early can we predict Alzheimer's disease using computational anatomy?
    Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
    Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of brain morphological changes related to aging and Alzheimer's disease from cross-sectional assessments.
    Sivera R; Delingette H; Lorenzi M; Pennec X; Ayache N;
    Neuroimage; 2019 Sep; 198():255-270. PubMed ID: 31121298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
    Schmitter D; Roche A; Maréchal B; Ribes D; Abdulkadir A; Bach-Cuadra M; Daducci A; Granziera C; Klöppel S; Maeder P; Meuli R; Krueger G;
    Neuroimage Clin; 2015; 7():7-17. PubMed ID: 25429357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations.
    Orellana C; Ferreira D; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    Neurodegener Dis; 2016; 16(1-2):77-86. PubMed ID: 26726737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
    Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
    J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.
    Elahi S; Bachman AH; Lee SH; Sidtis JJ; Ardekani BA;
    J Alzheimers Dis; 2015; 45(3):921-31. PubMed ID: 25633676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging of hippocampal atrophy in early recognition of Alzheimer's disease--a critical appraisal after two decades of research.
    Schröder J; Pantel J
    Psychiatry Res Neuroimaging; 2016 Jan; 247():71-8. PubMed ID: 26774855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
    Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
    Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease.
    Andrade de Oliveira A; Carthery-Goulart MT; Oliveira Júnior PP; Carrettiero DC; Sato JR
    J Alzheimers Dis; 2015; 43(1):201-12. PubMed ID: 25079801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Hänggi J; Streffer J; Jäncke L; Hock C
    J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects.
    Falahati F; Ferreira D; Soininen H; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Lovestone S; Eriksdotter M; Wahlund LO; Simmons A; Westman E;
    Brain Topogr; 2016 Mar; 29(2):296-307. PubMed ID: 26440606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.